286 related articles for article (PubMed ID: 9447254)
1. Viability determination of M.leprae: comparison of normal mouse foot pad and bacillary ATP bioluminescence assay.
Gupta UD; Katoch K; Natarajan M; Sharma VD; Sharma RK; Shivannavar CT; Katoch VM
Acta Leprol; 1997; 10(4):209-12. PubMed ID: 9447254
[TBL] [Abstract][Full Text] [Related]
2. Analysis of quantitative relationship between viability determination in leprosy by MFP, ATP bioluminescence and gene amplification assay.
Gupta UD; Katoch K; Sharma RK; Singh HB; Natragan M; Singh D; Sharma VD; Chauhan DS; Das R; Srivastava K; Katoch VM
Int J Lepr Other Mycobact Dis; 2001 Dec; 69(4):328-34. PubMed ID: 12035294
[TBL] [Abstract][Full Text] [Related]
3. Assessment of viability by normal mouse foot-pad and bacillary ATP bioluminescence assay in multibacillary cases treated with an MDT regimen using conventional as well as newer drugs like minocycline and ofloxacin.
Gupta UD; Katoch K; Singh HB; Natrajan M; Sharma VD; Katoch VM
Indian J Lepr; 2000; 72(4):437-42. PubMed ID: 11212477
[TBL] [Abstract][Full Text] [Related]
4. Comparative assessment of viability of M.leprae by mouse foot-pad and fluorescent staining techniques.
Sreevatsa ; Katoch VM
Indian J Lepr; 1994; 66(4):455-62. PubMed ID: 7714355
[TBL] [Abstract][Full Text] [Related]
5. Detection of viable organisms in leprosy patients treated with multidrug therapy.
Gupta UD; Katoch K; Singh HB; Natrajan M; Sharma VD; Katoch VM
Acta Leprol; 1999; 11(3):89-92. PubMed ID: 10544720
[TBL] [Abstract][Full Text] [Related]
6. Comparison of radiorespirometric Budemeyer assay with ATP assay and mouse foot pad test in detecting viable Mycobacterium leprae from clinical samples.
Agrawal VP; Shetty VP
Indian J Med Microbiol; 2007 Oct; 25(4):358-63. PubMed ID: 18087085
[TBL] [Abstract][Full Text] [Related]
7. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.
Dhople AM
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):183-8. PubMed ID: 6373626
[TBL] [Abstract][Full Text] [Related]
8. Effect of freezing Mycobacterium leprae in tissues.
Dhople AM
Lepr India; 1982 Jul; 54(3):461-70. PubMed ID: 6757579
[TBL] [Abstract][Full Text] [Related]
9. Isolation of mycobacterium leprae from untreated borderline tuberculoid, mid-borderline and indeterminate cases using the mouse foot pad technique--a study of 209 cases.
Wakade AV; Shetty VP
Lepr Rev; 2006 Dec; 77(4):366-70. PubMed ID: 17343223
[TBL] [Abstract][Full Text] [Related]
10. Correlation viability/morphology in Mycobacterium leprae.
Silva MT; Macedo PM; Portaels F; Pattyn SR
Acta Leprol; 1984; 2(2-4):281-91. PubMed ID: 6398588
[TBL] [Abstract][Full Text] [Related]
11. Effect of chemotherapy on viability of Mycobacterium leprae as determined by ATP content, morphological index and FDA-EB fluorescent staining.
Katoch VM; Katoch K; Ramanathan U; Sharma VD; Shivannavar CT; Datta AK; Bharadwaj VP
Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):615-21. PubMed ID: 2476522
[TBL] [Abstract][Full Text] [Related]
12. Growth of the ICRC bacilli in the foot-pad of mice.
Bapat CV; Modak MS
Lepr India; 1978 Apr; 50(2):144-55. PubMed ID: 353383
[TBL] [Abstract][Full Text] [Related]
13. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
Levy L; Ji B
Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
[TBL] [Abstract][Full Text] [Related]
14. Minocycline in lepromatous leprosy.
Fajardo TT; Villahermosa LG; dela Cruz EC; Abalos RM; Franzblau SG; Walsh GP
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):8-17. PubMed ID: 7730723
[TBL] [Abstract][Full Text] [Related]
15. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy.
Katoch K; Katoch VM; Natrajan M; Bhatia AS; Sreevatsa ; Gupta UD; Sharma VD; Shivannavar CT; Patil MA; Bharadwaj VP
Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):202-12. PubMed ID: 7602215
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of metabolism and growth of Mycobacterium leprae by gamma irradiation.
Adams LB; Soileau NA; Battista JR; Krahenbuhl JL
Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):1-10. PubMed ID: 10834063
[TBL] [Abstract][Full Text] [Related]
17. Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa ; Sharma VD; Shivannavar CT; Katoch VM
Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):451-7. PubMed ID: 2664042
[TBL] [Abstract][Full Text] [Related]
18. Study of the involvement of the sciatic nerve following inoculation with M. leprae and other mycobacteria in the mouse foot pad.
Kamala AN; Antia NH; Shetty VP
Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):506-14. PubMed ID: 6100185
[TBL] [Abstract][Full Text] [Related]
19. Immunological potential of a cultivable mycobacterial strain M. habana against leprosy bacillus in mouse foot pad.
Singh NB; Srivastava ; Gupta HP; Sreevatsa ; Desikan KV
Indian J Lepr; 1985; 57(2):278-81. PubMed ID: 3908575
[TBL] [Abstract][Full Text] [Related]
20. Adenosine triphosphate content of Mycobacterium leprae: effect of purification procedures.
Dhople AM; Storrs EE
Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):83-9. PubMed ID: 7042615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
